ROX Medical
- Company typePrivate
- Founded2004
- HeadquartersSan Clemente, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
ROX Medical firmographics
Firmographics- Name
- ROX Medical
- Website
- https://roxmedical.com
- Company type
- Private
- Founded year
- 2004
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
ROX Medical industry classification
Industry- Product category
- Interventional Pulmonology Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- COPD & Chronic Bronchitis Management (HLAKANAE)
- akta.pro secondary industry
- Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM)
Keywords
Where ROX Medical is headquartered
LocationHeadquarters
- HQ city
- San Clemente
- HQ country
- United States
- HQ region
- North America
Markets served
ROX Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
ROX Medical product offering
Product offeringCore offering
ROX Medical develops innovative medical devices for the treatment of chronic obstructive pulmonary disease (COPD). The company focuses on interventional device-based therapies intended for patients with chronic lung disease, operating within the respiratory medical device sector.
Differentiator
Problem solved
Functional benefit
Companies that use ROX Medical
Customer profileIdeal customer profiles1 record
ROX Medical technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
ROX Medical partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights3 records
ROX Medical competitors and assessment
Company assessmentDirect peers
- Pulmonx: Pulmonx develops the Zephyr endobronchial valve system for emphysema/COPD patients, the most directly comparable interventional device competitor to ROX Medical in the COPD treatment space.
- CSA Medical: CSA Medical markets the RejuvenAir metered cryospray system for chronic bronchitis, a direct niche peer in interventional device therapy for COPD-related chronic bronchitis.
- Broncus Medical: Broncus Medical develops interventional pulmonology tools (e.g., Archimedes virtual bronchoscopy and biopsy tools), serving the same interventional pulmonologist customer base treating COPD and emphysema.
Broad incumbents
- Olympus (Spiration): Olympus owns the Spiration intrabronchial valve system for emphysema and is a broad respiratory/bronchoscopy incumbent offering overlapping interventional COPD capabilities as part of a larger portfolio.
- BTG / PneumRx (Johnson & Johnson): PneumRx developed RePneu coils for emphysema and was acquired by BTG (later J&J); represents a comparable interventional COPD device pathway and a relevant consolidation benchmark.
Emerging players
- Gala Therapeutics: Gala Therapeutics is developing interventional catheter-based therapies for chronic bronchitis and COPD, partially overlapping with ROX Medical's disease focus and interventional approach.
- Aerin Medical: Aerin Medical develops minimally invasive office-based nasal airway and related ENT/airway interventions, an emerging player with partial thematic overlap in interventional airway procedures.
- Uptake Medical: Uptake Medical developed the InterVapor bronchoscopic thermal vapor ablation system for emphysema, a niche interventional COPD peer with comparable mechanism and clinical positioning.
- Holaira (now Nuvaira): Nuvaira (formerly Holaira) developed targeted lung denervation for COPD, an interventional device peer targeting the same disease via a distinct mechanism, now backed by private capital.
Regional players
- Inspire Medical Systems: Inspire Medical Systems is an implantable neurostimulation company; though focused on sleep apnea rather than COPD, it serves as a relevant public-comparable for small-cap U.S. medtech companies commercializing implantable specialty devices.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
ROX Medical social profiles
Digital presenceROX Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
ROX Medical leadership team
Management profileNumber of profiles
ROX Medical funding detail
Funding detailFunding overview
Funding rounds6 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ROX Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ROX Medical
What does ROX Medical do?
ROX Medical develops innovative medical devices for the treatment of chronic obstructive pulmonary disease (COPD). The company focuses on interventional device-based therapies intended for patients with chronic lung disease, operating within the respiratory medical device sector.
When was ROX Medical founded?
ROX Medical was founded in 2004. It employs 11 to 50 people.
Where is ROX Medical based?
ROX Medical is headquartered in San Clemente, United States, in the North America region.
Who are ROX Medical's main competitors?
Direct peers on record are Pulmonx, CSA Medical and Broncus Medical. Broad incumbents are Olympus (Spiration) and BTG / PneumRx (Johnson & Johnson). Emerging players are Gala Therapeutics, Aerin Medical, Uptake Medical and Holaira (now Nuvaira). Inspire Medical Systems is listed as a regional player.
Does ROX Medical have an API?
No public API is recorded for ROX Medical.
What industry is ROX Medical in?
ROX Medical's product category is Interventional Pulmonology Devices. Its primary akta.pro industry code is HLAKANAE, COPD & Chronic Bronchitis Management, with a secondary code of HLAKANAM, Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management. Its NAICS code is 339112 and its SIC code is 3841.